FilingReader Intelligence
Gufic BioSciences increases stake in pharmaceutical subsidiary to 60%
July 15, 2025 at 12:40 PM UTC•By FilingReader AI
Gufic BioSciences Limited acquired 512,000 equity shares in subsidiary Gufic Prime Private Limited for Rs. 512,000 through a rights issue completed July 14, 2025.
The acquisition increased Gufic BioSciences' total shareholding in GPPL to 60%, bringing its holding to 600,000 equity shares. GPPL, incorporated in November 2023, is engaged in marketing, distribution, and sale of pharmaceutical products.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:GUFICBIO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Gufic BioSciences publishes news
Free account required • Unsubscribe anytime